Dexmedetomidine attenuation of renal ischaemia-reperfusion injury requires sirtuin 3 activation
Dexmedetomidine attenuation of renal ischaemia-reperfusion injury requires sirtuin 3 activation
复制标题
右美托咪定减轻肾缺血再灌注损伤需要激活 Sirtuin 3
DOI:
10.1016/j.bja.2018.07.007
复制
发表时间:
2018-12-01
影响因子:
9.8
通讯作者:
Geng, Y.
中科院分区:
文献类型:
--
作者:
Si, Y.;Bao, H.;Geng, Y.
Background: Dexmedetomidine attenuates renal ischaemia and reperfusion (I/R) injury, but its mechanism of action is unclear. As sirtuin 3 (SIRT3) activation can alleviate acute kidney injury, we investigated whether dexmedetomidine acts through SIRT3 to reduce renal I/R injury.Methods: The potential involvement of SIRT3 in dexmedetomidine attenuation of renal I/R injury was tested in HK2 cells subjected to hypoxia/reoxygenation and C57BL/6J mice subjected to renal I/R. A short interfering RNA targeting SIRT3 was used in some experiments to examine the potential role of SIRT3. Cell death and mitochondrial membrane potential (Atm) were analysed in cultured cells. Mitochondrial damage in mice was assessed using electron microscopy and markers for renal function. Expression of cyclophilin D, cytochrome c, and SIRT3, and the level of cyclophilin D acetylation were determined.Results: Hypoxia/reoxygenation of HK2 cells increased cell death, cytochrome C expression, and cyclophilin D acetylation, and decreased Acl.ffn and SIRT3 expression (P